EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings

Fahad S Alshehri iD

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s402362 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Fahad S Alshehri. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. Hauptthemen laut MEDLINE: Tramadol, Neuralgia, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TramadolNeuralgiaDrug-Related Side Effects and Adverse ReactionsHumansTapentadolAnalgesics, OpioidPhenolsAnalgesics

Stichwörter der Autor:innen

chronic painclinical trialsneuropathic painopioids

Substanzen

TapentadolAnalgesics, OpioidTramadolPhenolsAnalgesics

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.

ORCID-Profile: Fahad S Alshehri

Zitieren

APA

Alshehri, F. S. (2023). Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s402362

Vancouver

Alshehri FS. Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s402362

BibTeX
@article{Alshehri2023,
  author = {Alshehri, Fahad S},
  title = {Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s402362}
}
Kostenlos starten →